Ferroptosis: friend or foe in cancer immunotherapy?
Immunogenic cell death
cancer immunosuppression
immunogenic ferroptosis
Journal
Oncoimmunology
ISSN: 2162-402X
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
2023
2023
Historique:
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
8
3
2023
Statut:
epublish
Résumé
Ferroptosis has gained interest due to it immunogenicity and the higher sensitivity of cancer cells to it. However, it was recently shown that ferroptosis in tumor-associated neutrophils leads to immunosuppression and negatively impacts therapy. Here, we discuss the potential implications of the two sides (friend
Identifiants
pubmed: 36875549
doi: 10.1080/2162402X.2023.2182992
pii: 2182992
pmc: PMC9980624
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2182992Informations de copyright
© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.
Déclaration de conflit d'intérêts
Authors declare no conflict of interests.
Références
J Immunother Cancer. 2021 Dec;9(12):
pubmed: 34903554
Nature. 2022 Dec;612(7939):338-346
pubmed: 36385526
Mol Med. 2012 Dec 20;18:1360-2
pubmed: 23073660
Immunity. 2021 Apr 13;54(4):721-736.e10
pubmed: 33725478
Cell Metab. 2021 Aug 3;33(8):1701-1715.e5
pubmed: 34118189
Nat Commun. 2020 Dec 7;11(1):6299
pubmed: 33288764
Nat Commun. 2022 Jun 27;13(1):3676
pubmed: 35760796
Nat Rev Cancer. 2019 Jul;19(7):405-414
pubmed: 31101865
J Immunother Cancer. 2020 Nov;8(2):
pubmed: 33188036
Nat Immunol. 2022 Apr;23(4):487-500
pubmed: 35145297
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Autophagy. 2022 Sep;18(9):2036-2049
pubmed: 34964698
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970